Canali Minisiti ECM

D. Santini ♫

Redazione DottNet | 08/03/2023 10:01

Monarch 2: Overall Survival of Abemaciclib plus Fuvestrant in patients with HR+ HER2- advanced breast cancer

I Correlati

Da non perdere